Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow.
about
Thrombotic microangiopathy with targeted cancer agentsPathogenesis of thrombotic microangiopathiesHemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimersProteolytic processing of von Willebrand factor by adamts13 and leukocyte proteasesIdiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment OptionsRelevance of ADAMTS13 to liver transplantation and surgeryActivated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectinInflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cellsEmerging drugs for chronic lymphocytic leukaemia.Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings.Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.Systemic antithrombotic effects of ADAMTS13.Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura.Differential role of von Willebrand factor and P-selectin on microvascular thrombosis in endotoxemia.Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failureElevated procalcitonin and C-reactive protein as potential biomarkers of sepsis in a subpopulation of thrombotic microangiopathy patientsThrombotic microangiopathies: multimers, metalloprotease, and beyond.Plasma exchange therapy for thrombotic microangiopathies.Idiopathic noncirrhotic intrahepatic portal hypertension is associated with sustained ADAMTS13 Deficiency.Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan.Factors predicting persistent thrombocytopenia after living donor liver transplantation in pediatric patients.A case of thrombotic thrombocytopenic purpura induced by acute pancreatitis.Presence of anti-ADAMTS13 antibodies in obesity.Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.The oxidative modification of von Willebrand factor is associated with thrombotic angiopathies in diabetes mellitusHigh frequency of acquired ADAMTS13 deficiency after hemolysis in Hemiscorpius Lepturus (scorpion) stung children.Alcohol-induced severe acute pancreatitis followed by hemolytic uremic syndrome managed with continuous renal replacement therapy.VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP.Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malariaSevere Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibitionRibosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpuraThrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury.A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malariaThrombotic microangiopathy without renal involvement: two novel mutations in complement-regulator genes.Acute pancreatitis-induced thrombotic thrombocytopenic purpura with recurrent acute pancreatitis.Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13.Assessment of endothelial function as a marker of cardiovascular risk in patients with rheumatoid arthritis.Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor.The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation
P2860
Q24635904-05865431-F410-4DED-9B4C-87351E68E567Q24658043-65877DB1-85E2-4907-8FE2-A0D77BA74861Q24669689-09BE9ECC-94B1-4DBD-84A3-6E16385612E7Q26827966-13DED373-BED1-4320-9229-EAF038B4DE4DQ28084761-424A7C0F-4C28-4B8F-95FB-BAE3F68F3E18Q28085109-9834DDD7-DA18-4C39-8B31-B2427E1D09EBQ28512587-620D2221-6B66-4180-980B-FF46D5185D25Q28564426-17FCEC8B-599F-4883-A70A-F3AFB5ACFBACQ30353154-457216F7-F4BC-405C-B4DD-5B9C1C15E4E7Q30493763-9097CDFB-4894-412A-A298-04703BD790EBQ33369765-4EB5F0E1-6332-4081-991F-B3520D0A09DEQ33370540-6CA14A9E-334D-4755-8E4B-B075FF4BDCA7Q33371690-130BAE33-6728-4648-82C9-A9483C84D657Q33381217-06F0524A-AA80-4B0A-B987-7E94ED761528Q33381364-2ACC01EF-A4E6-4A53-B82E-98DEDC2DBC6EQ33385335-F874BF18-B3CC-466C-896E-4783467FE969Q33389435-FA4E43A2-DF09-4EAC-A63B-9D82695662D1Q33393983-1A1CA8B3-AC7F-4EE9-8A90-1D7088EEF01FQ33395323-9197B354-00E2-41B9-867F-EBE793EA3F50Q33396314-F2F14C7F-D1F8-4490-82A6-08CC8AFC1219Q33396362-7E37B6ED-4794-4D06-8ECB-F84AE7E68B5BQ33400944-D37E12F0-92EA-4F60-B4A6-16B7F6B0D8B3Q33403187-3261A652-A7B1-49F9-B2CE-28BFEE53526CQ33403225-C18353B2-420D-4D0B-95A7-52042041B52CQ33405692-947F5181-300F-48CF-9843-0B1A4633718CQ33409389-73CB0A3B-3A16-4C63-9B5A-3ABD0E2CC709Q33412440-7AB376E2-5086-4025-AF0C-E09E939D2B1CQ33419324-7B4A18C8-D8C7-4DEC-A862-5802AAFD5CB2Q33419656-87A62114-F441-4C90-A26C-ED86BDE8B427Q33419829-6D5BDE3F-9B30-4BB3-901D-6071FED6E1A0Q33420289-60378F61-0203-48A4-AC1E-377744064EDBQ33426245-FB5986CC-1B2E-441F-A0D4-5D75B94BEDD5Q33427139-59990BE5-EFB6-4218-BE39-4A3D8A63ED48Q33427932-98AD9024-73B2-4A9D-BAFB-79CF64D21513Q33430220-D46B0766-EC75-4ED7-BC22-26AA562B3710Q33430748-0073D149-CC59-4F6E-9A7E-B6D32B07967FQ33608705-9DA12287-B173-4DCF-B647-BD8437DCE705Q33655500-6938CE45-1CF9-4AB9-96FA-529BFD72CB54Q33747303-33F9E42E-253C-4C27-9E01-380254FAE35AQ33751764-7CED6393-CF46-4B18-8DB1-755DDC196519
P2860
Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Effects of inflammatory cytoki ...... d factor multimers under flow.
@en
Effects of inflammatory cytoki ...... d factor multimers under flow.
@nl
type
label
Effects of inflammatory cytoki ...... d factor multimers under flow.
@en
Effects of inflammatory cytoki ...... d factor multimers under flow.
@nl
prefLabel
Effects of inflammatory cytoki ...... d factor multimers under flow.
@en
Effects of inflammatory cytoki ...... d factor multimers under flow.
@nl
P2093
P1433
P1476
Effects of inflammatory cytoki ...... d factor multimers under flow.
@en
P2093
Aubrey Bernardo
Chalmette Ball
Jing-fei Dong
Joel F Moake
Leticia Nolasco
P304
P356
10.1182/BLOOD-2004-01-0107
P407
P577
2004-03-16T00:00:00Z